Wei Mu

TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors

Na Tang, Chen Cheng, Xingying Zhang et al. · JCI Insight · 2020 · 390 citations · Full text

Life Sciences, Immunology, Oncology +17

Non-invasive decision support for NSCLC treatment using PET/CT radiomics

Wei Mu, Lei Jiang, Jianyuan Zhang et al. · Nature Communications · 2020 · 296 citations · Full text

Medicine, Oncology, Radiology +17

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang et al. · Signal Transduction and Targeted Therapy · 2023 · 283 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study

Qiuhe Wang, Dongdong Xia, Wei Bai et al. · Journal of Hepatology · 2019 · 266 citations

Medicine, Oncology, Hepatology +13

CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells

Yongping Zhang, Xingying Zhang, Chen Cheng et al. · Frontiers of Medicine · 2017 · 231 citations

Life Sciences, Immunology, Molecular Biology +11